These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

415 related articles for article (PubMed ID: 28199816)

  • 1. Survival and Neurodevelopmental Outcomes among Periviable Infants.
    Younge N; Goldstein RF; Bann CM; Hintz SR; Patel RM; Smith PB; Bell EF; Rysavy MA; Duncan AF; Vohr BR; Das A; Goldberg RN; Higgins RD; Cotten CM;
    N Engl J Med; 2017 Feb; 376(7):617-628. PubMed ID: 28199816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in neurodevelopmental outcomes at 18 to 22 months' corrected age among infants of less than 25 weeks' gestational age born in 1993-1999.
    Hintz SR; Kendrick DE; Vohr BR; Poole WK; Higgins RD;
    Pediatrics; 2005 Jun; 115(6):1645-51. PubMed ID: 15930228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of Neurodevelopmental Outcomes and Neonatal Morbidities of Extremely Premature Infants With Differential Exposure to Antenatal Steroids.
    Chawla S; Natarajan G; Shankaran S; Pappas A; Stoll BJ; Carlo WA; Saha S; Das A; Laptook AR; Higgins RD;
    JAMA Pediatr; 2016 Dec; 170(12):1164-1172. PubMed ID: 27723868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved survival and neurodevelopmental outcomes among extremely premature infants born near the limit of viability.
    Younge N; Smith PB; Gustafson KE; Malcolm W; Ashley P; Cotten CM; Goldberg RN; Goldstein RF
    Early Hum Dev; 2016 Apr; 95():5-8. PubMed ID: 26900775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurodevelopmental outcomes of preterm infants conceived by assisted reproductive technology.
    Roychoudhury S; Lodha A; Synnes A; Abou Mehrem A; Canning R; Banihani R; Beltempo M; Theriault K; Yang J; Shah PS; Soraisham AS; ; ;
    Am J Obstet Gynecol; 2021 Sep; 225(3):276.e1-276.e9. PubMed ID: 33798481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurodevelopmental Outcomes of Infants at <29 Weeks of Gestation Born in Canada Between 2009 and 2016.
    Ricci MF; Shah PS; Moddemann D; Alvaro R; Ng E; Lee SK; Synnes A;
    J Pediatr; 2022 Aug; 247():60-66.e1. PubMed ID: 35561804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Higher or Lower Hemoglobin Transfusion Thresholds for Preterm Infants.
    Kirpalani H; Bell EF; Hintz SR; Tan S; Schmidt B; Chaudhary AS; Johnson KJ; Crawford MM; Newman JE; Vohr BR; Carlo WA; D'Angio CT; Kennedy KA; Ohls RK; Poindexter BB; Schibler K; Whyte RK; Widness JA; Zupancic JAF; Wyckoff MH; Truog WE; Walsh MC; Chock VY; Laptook AR; Sokol GM; Yoder BA; Patel RM; Cotten CM; Carmen MF; Devaskar U; Chawla S; Seabrook R; Higgins RD; Das A;
    N Engl J Med; 2020 Dec; 383(27):2639-2651. PubMed ID: 33382931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes of Extremely Preterm Infants With Birth Weight Less Than 400 g.
    Brumbaugh JE; Hansen NI; Bell EF; Sridhar A; Carlo WA; Hintz SR; Vohr BR; Colaizy TT; Duncan AF; Wyckoff MH; Baack ML; Rysavy MA; DeMauro SB; Stoll BJ; Das A; Higgins RD;
    JAMA Pediatr; 2019 May; 173(5):434-445. PubMed ID: 30907941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurodevelopmental and Behavioral Outcomes in Extremely Premature Neonates With Ventriculomegaly in the Absence of Periventricular-Intraventricular Hemorrhage.
    Pappas A; Adams-Chapman I; Shankaran S; McDonald SA; Stoll BJ; Laptook AR; Carlo WA; Van Meurs KP; Hintz SR; Carlson MD; Brumbaugh JE; Walsh MC; Wyckoff MH; Das A; Higgins RD;
    JAMA Pediatr; 2018 Jan; 172(1):32-42. PubMed ID: 29181530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early-childhood neurodevelopmental outcomes are not improving for infants born at <25 weeks' gestational age.
    Hintz SR; Kendrick DE; Wilson-Costello DE; Das A; Bell EF; Vohr BR; Higgins RD;
    Pediatrics; 2011 Jan; 127(1):62-70. PubMed ID: 21187312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurodevelopmental and growth impairment among extremely low-birth-weight infants with neonatal infection.
    Stoll BJ; Hansen NI; Adams-Chapman I; Fanaroff AA; Hintz SR; Vohr B; Higgins RD;
    JAMA; 2004 Nov; 292(19):2357-65. PubMed ID: 15547163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurodevelopmental Outcomes of Infants Born at <29 Weeks of Gestation Admitted to Canadian Neonatal Intensive Care Units Based on Location of Birth.
    Amer R; Moddemann D; Seshia M; Alvaro R; Synnes A; Lee KS; Lee SK; Shah PS;
    J Pediatr; 2018 May; 196():31-37.e1. PubMed ID: 29305231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histologic chorioamnionitis and risk of neurodevelopmental impairment at age 10 years among extremely preterm infants born before 28 weeks of gestation.
    Venkatesh KK; Leviton A; Hecht JL; Joseph RM; Douglass LM; Frazier JA; Daniels JL; Fry RC; O'Shea TM; Kuban KCK
    Am J Obstet Gynecol; 2020 Nov; 223(5):745.e1-745.e10. PubMed ID: 32387324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurodevelopmental outcome at 2 years for preterm children born at 22 to 34 weeks' gestation in France in 2011: EPIPAGE-2 cohort study.
    Pierrat V; Marchand-Martin L; Arnaud C; Kaminski M; Resche-Rigon M; Lebeaux C; Bodeau-Livinec F; Morgan AS; Goffinet F; Marret S; Ancel PY;
    BMJ; 2017 Aug; 358():j3448. PubMed ID: 28814566
    [No Abstract]   [Full Text] [Related]  

  • 15. Association of Antenatal Corticosteroids With Mortality, Morbidity, and Neurodevelopmental Outcomes in Extremely Preterm Multiple Gestation Infants.
    Boghossian NS; McDonald SA; Bell EF; Carlo WA; Brumbaugh JE; Stoll BJ; Laptook AR; Shankaran S; Walsh MC; Das A; Higgins RD;
    JAMA Pediatr; 2016 Jun; 170(6):593-601. PubMed ID: 27088897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes of infants born at 22 and 23 weeks' gestation.
    Ishii N; Kono Y; Yonemoto N; Kusuda S; Fujimura M;
    Pediatrics; 2013 Jul; 132(1):62-71. PubMed ID: 23733804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trends in the neurodevelopmental outcomes among preterm infants from 2003-2012: a retrospective cohort study in Japan.
    Nakanishi H; Suenaga H; Uchiyama A; Kono Y; Kusuda S;
    J Perinatol; 2018 Jul; 38(7):917-928. PubMed ID: 29679045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Randomized Trial of Erythropoietin for Neuroprotection in Preterm Infants.
    Juul SE; Comstock BA; Wadhawan R; Mayock DE; Courtney SE; Robinson T; Ahmad KA; Bendel-Stenzel E; Baserga M; LaGamma EF; Downey LC; Rao R; Fahim N; Lampland A; Frantz ID; Khan JY; Weiss M; Gilmore MM; Ohls RK; Srinivasan N; Perez JE; McKay V; Vu PT; Lowe J; Kuban K; O'Shea TM; Hartman AL; Heagerty PJ;
    N Engl J Med; 2020 Jan; 382(3):233-243. PubMed ID: 31940698
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survival and major neurodevelopmental impairment in extremely low gestational age newborns born 1990-2000: a retrospective cohort study.
    Washburn LK; Dillard RG; Goldstein DJ; Klinepeter KL; deRegnier RA; O'Shea TM
    BMC Pediatr; 2007 May; 7():20. PubMed ID: 17477872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of Antenatal Corticosteroids and Magnesium Sulfate Therapy With Neurodevelopmental Outcome in Extremely Preterm Children.
    Gentle SJ; Carlo WA; Tan S; Gargano M; Ambalavanan N; Chawla S; Bell EF; Bann CM; Hintz SR; Heyne RJ; Tita A; Higgins RD;
    Obstet Gynecol; 2020 Jun; 135(6):1377-1386. PubMed ID: 32459430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.